Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant

Immunodeficient individuals often rely on donor-derived immunoglobulin (Ig) replacement therapy (IGRT) to prevent infections. The passive immunity obtained by IGRT is limited and reflects the state of immunity in the plasma donor population at the time of donation. The objective of the current study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindahl, Hannes, Klingström, Jonas, Da Silva Rodrigues, Rui, Christ, Wanda, Chen, Puran, Ljunggren, Hans-Gustaf, Buggert, Marcus, Aleman, Soo, Smith, C. I. Edvard, Bergman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090539/
https://www.ncbi.nlm.nih.gov/pubmed/35538387
http://dx.doi.org/10.1007/s10875-022-01283-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090539/
https://www.ncbi.nlm.nih.gov/pubmed/35538387
http://dx.doi.org/10.1007/s10875-022-01283-9

Ejemplares similares